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Cancer is a disease which has long been shrouded in mystery, but
our knowledge of its intricacies has been extended in numerous
directions by investigations carried on in all parts of the world by
workers in many branches of science. Yet it remains true that in
general we are not able to explain the origin of cancer, and the
methods of treatment at present available are pitifully inadequate.
These facts provide ample justification for the most painstaking and
persistent pursuit, with all the resources that can be brought to bear
upon them, of any clues that may be forthcoming, however slender
and unpromising they may seem to be.
One of the most fruitful lines of cancer research in recent years
has provided the demonstration that cancer may be produced at will
in a majority of the animals treated, with a variety of chemical com-
pounds. For the most part these compounds have been prepared
synthetically and their molecular structure is known. They retain
their activity undiminished after a high degree of purification. The
cancers which may thus be induced experimentally are indistinguish-
able in their characteristics from the cancers which afflict mankind.
Histologically they conform to many different types; they can arise
in avarietyof organs in the body, and they showthe accepted criteria
of malignancy, such as invasion of normal tissue and the production
of secondary growths. We are not, of course, justified in inferring
from this that human cancer is of chemical origin. All we can say is
that there are a large number of experimental observations which
are consistent with the view that the factor which initiates the onset
of malignancy may in some cases be a chemical compound or com-
pounds. Indeed, it is now an established fact that the aestrogenic
hormones, which are relatively simple chemical compounds of
normal occurrence in the body, can play a role in the xtiology of
certain specific types of experimental cancer, namely, carcinoma of
the mamma in mice. In some circumstances, however, it seems
likely that hereditary factors play an even greater part in this form
of cancer and it would be premature to suggest that excessive secre-
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tion of cestrogenic hormones is the controlling factor in the develop-
ment of similar cancers in women. Nevertheless, there are strong
indications that these hormonal factors are worthy of attention in
the study of cancer.
Another fact of great interest is the relative ease with which such
naturally occurring compounds of widespread occurrence as choles-
terol and the bile acids may be chemically transformed in vitro into
a, compound which can act regularly and powerfully in inducing
cancer experimentally. The malignant tumours formed under the
influence of this sterol transformation product usually arise locally
at the site of application. We are thus presented with the interest-
ing speculation that cancer may be a disease of faulty metabolism
caused by the abnormal degradation of sterol-like compounds to
chemical agents which can initiate malignancy. This conception is
susceptible to experimental investigation, although numerous tech-
nical difficulties arise and it may be years before it is possible to
secure conclusive proof or disproof.
Another view of the origin of cancer which has had considerable
vogue for more than 25 years is held by a school of cancer research
workers who regard a sub-microscopic organism or virus as being
the principal xtiological factor in cancer. For many years this view
depended for its experimental support upon evidence obtained with
the filterable tumours of birds. Hence, widespread interest was
a,roused by an observation made a few years ago by Peyton Rous,
who studied the benign warts found in the cotton-tail rabbit, which
$hope had shown to be capable of transmission by cell-free extracts
,when inoculated into other cotton-tail rabbits. Rous found that the
yirus which these benign tumours contained would induce malignat
tumours when injected into domestic rabbits. Further intensive
investigation has shown however, that the production of cancer in
this manner is a process which is akin to cancer production by a
clhemical agent rather than by the tumour viruses of fowls. More-
over, the important work of Wyckoff has demonstrated fairly con-
vincingly that the active agent of the Shope papilloma is a protein
Qfhigh molecularweight. In this waytwo completely different lines
o,f,investigation of cancer have converged in an astonishing manner,
fQr the outcome ofthese virus studies has been to reveal the existence
of' a new type of chemical carcinogenic agent having the character
of a protein.
Before discussing the structural relationships among the poly-
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cyclic hydrocarbons with which my colleagues and I have been
chiefly occupied, I would point out that there is evidence that other
types ofcompound have cancer-producing activity. Thus, Browning
has observed the production of sarcomas in mice following the injec-
tion of a styryl quinoline derivative of the structure shown, which
he and J. B. Cohen had synthesised and found to have trypanocidal
properties.
CH5C0 ,NH 9° .:9-CH=CH NNH2
}O.CO.CHS
Also, a large volume of work of outstanding importance and
merit has been turned out from a number of Japanese laboratories.
The Japanese workers have followed up clues first provided by
B. Fischer as early as 1906. Fischer had shown that the injection
of Scarlet Red (Biebrich Scarlet R medicinal) into the ears of rabbits
led to an epithelial proliferation very like cancer, but it was not
malignant. This discovery led to the employment of this dyestuff
to accelerate wound-healing, in which connection it was subsequently
found that the active part of the molecule was contained in
o-aminoazotoluene (4'-amino-2: 3'-azotoluene). To Yoshidais due
the credit of demonstrating that o-aminoazotoluene is a carcinogenic
agent. Unlike the polycyclic hydrocarbons to be discussed later this
azo compound gives no tumours either of the skin or at the site of
subcutaneous injection, but gives cancer of the liver when fed in
large doses to rats and mice, and also after subcutaneous injection.
In addition, this aminoazotoluene was found to give papilloma of
the urinary bladder in some of the rats to which it was fed. The
related 2: 3'-azotoluene was shown by Otsuka and Nagao to have
a much more pronounced carcinogenic action on the urinary bladder
when administered to rats with their food, but no longer gave cancer
of the liver. Nagao also found that the related 4'-hydroxy-2: 3'-
azotoluene gave papilloma of the bladder in rats. Finally, Kinosita
has shown that p-dimethylaminoazobenzene, isomeric with o-amino-
azotoluene, is carcinogenic towards the liver, and also gave tumours
of the stomach in some of the animals to which it was fed. Fortu-
nately the name applied to this last compound, namely, "butter
yellow," no longer has the significance which formerly attached to
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it. It is unlikely that this compound is now used as a food colouring
matter.
NH3 N=N X ON=N NH2
Scarlet R o-Aminoazotoluene
3: 4-Benzpyrete, a Camwer-producing Constituent of Coal Tar
It has been known since the eighteenth century that certain forms
of skin cancer constitute an industrial disease to which workers
engaged in specific occupations are specially liable. This was first
recognised inthe so-called chimney-sweepers' cancerwhich a London
surgeon, Percival Pott, described as being due to repeated contact
of the skin with soot. The carcinogenic principle of the soot may,
in fact, be extracted with ether and can be used to produce cancer
of the skin in mice, as was first shown by Passey in 1922. The
liability to industrial skin cancer is shown also by operatives engaged
in handling coal tar and coal tar products, shale distillates and
products obtained therefrom, and many mineral lubricating oils.
In the case ofcoal tarthe main component responsible for the cancer-
producing properties has been isolated and synthesised in the labora-
tories of the Royal Cancer Hospital; it was shown to be 3: 4-benz-
pyrene by the following scheme of synthesis:
CHICO e t
CO2H
In this scheme the position attacked in the Friedel-Crafts reaction
between pyrene and succinic anhydride is assumed by analogy.
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This does not affect the validity of the conclusion regarding the
structure of the final pentacydic hydrocarbon, however, as only two
benzpyrenes are theoretically possible, and the alternative 1: 2-
benzpyrene, different from that obtained in the above synthesis, was
prepared by another method which left no doubt as to its structure.
In the experiments leading to the isolation of benzpyrene from
coal tar, studies of fluorescence spectroscopy, initiated by Mayneord
and continued by Hieger, played an important part. 3:4-Benz-
pyrene is characterised by a very powerful and persistent violet
fluorescence, thespectrum ofwhich appears to consist ofthree charac-
teristic bands if examined at low dispersions. These same bands
were detected in many complex carcinogenic mixtures, including not
only coal tar and its products, but also a mixture obtained by
Schroeter by the action of aluminium chloride on tetralin, and
shown by Kennaway to be carcinogenic. Probably 3: 4-benzpyrene
is present in this mixture, and although it has not been conclusively
demonstrated that the same hydrocarbon is the active carcinogenic
agent present in shale oil and other lubricating oils, the available
evidence makes it inherently probable that the active compound is
either 3: 4-benzpyrene or a closely related compound.
The powerful fluorescence of benzpyrene, with its characteristic
spectrum, has been utilised by several investigators who have made
experimental studies of its behaviour in the animal body. Allusion
may be made in particular to the work of Peacock, who injected
aqueous colloidal solutions of benzpyrene intravenously into rabbits,
guinea-pigs, mice, and fowls. He found that the body fats gave
the fluorescence spectrum of benzpyrene within 15 to 30 minutes
after injection, and fluorescent droplets appeared in the liver cells.
During the few hours which succeeded, fluorescence appeared in the
bile, but the spectrum was different from that of benzpyrene, indi-
cating that chemical transformation, possibly not of an extensive
character, had taken place.
At this stage reference may be made to the manner in which the
carcinogenic properties ofbenzpyrene maybe demonstrated. Similar
considerations apply also to the other polycyclic hydrocarbons which
have been found carcinogenic. The main differences between them
are quantitative rather than qualitative. That is to say, the com-
pounds give tumours of similar types, in the same organs, with
similardegrees ofmalignancy. Theydiffer, however, in therapidity
with which tumours arise, and in the proportion of the animals which
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develop tumours. 3: 4-Benzpyrene is one of the more active car-
cinogenic compounds, and if a drop of a 0.3 per cent solution in
benzene is applied twice a week to the back of a mouse tumours
begin to appear after about 80 to 100 days. With certain other
compounds this latent period is rather less than this, but with the
majority of them it is greater and may be as much as 300 to 400
days or even more. The first visible signs of tumours consist of
the appearance of one or more small warts on the skin. These
grow, usually fairly rapidly, and where there are several they often
coalesce into one large horny mass of tumour which at the same
time penetrates the deeper tissues of the animal, showing invasion
of muscle and other criteria of malignancy. Such tumours are
epitheliomas which belong to the class of malignant tumours known
as carcinomas. These are usually squamous-celled in character, but
have sometimes been spindle-celled. If the same compound is
injected into the subcutaneous tissues of the rats, mice, or fowls,
then rapidly growing spindle-celled tumours arise which conform to
the type of cancer known as sarcoma. It has been made clear from
these results that the principal etiological differences between car-
cinomas and sarcomas lie in the tissues which give rise to the
malignant cells.
Methylcholantthrene
Another carcinogenic hydrocarbon which merits special consid-
eration is methylcholanthrene. As is perhaps apparent from its
name, this hydrocarbon is related to the cholane (bile acid) group
of natural products and it was in fact first obtained from deoxycholic
acid (i.e., 3: 12-dihydroxycholanic acid) independently by Wieland
and Dane and also by Haslewood and myself. The changes
involved in this transformation are all of a comparatively simple
type and it appeared of some significance that this bile acid has in
its molecule a hydroxyl group in a suitable position to facilitate
cyclisation of the aliphatic side chain to give rise to a ring system
which was already known to be associated with carcinogenic proper-
ties. Proof that such cyclisation does, in fact, occur in vivo is still
lacking and this applies also with regard to the extensive dehydro-
genation of the ringsystem which appears necessary for the develop-
ment of carcinogenic properties.
Fieser subsequently showed that methylcholanthrene could be
obtained also by similar reactions from cholic acid (3: 7: 12-trihy-
droxycholanic acid). Cholic acid and deoxycholic acid comprise the
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principal acids of human bile. Even greater interest attaches to the
recent observations of Rossner, working in Windaus's laboratory,
who found that methylcholanthrene could be obtained by dehydro-
genation with selenium at 3600 of the complex hydrocarbazole
derivatives which are formed by condensation of cholestenone and
cholestanone with phenylhydrazine. In the complex reactions
which accompany dehydrogenation the nitrogenous portion of the
molecule and part of the side chain are simultaneously eliminated.
Hydrocarbazole derivative Methyicholanthrene
from cholestanone
It seems to me that this reaction, involving a sterol derivative in
which, unlike the bile acids, hydroxy groups are not present to
promote cyclisation, indicates an inherent tendency on the part of
the sterol side chain to undergo cyclisation to ahydrogenated methyl-
cholanthrene derivative, and the implications of this view are worthy
of widespread experimental study.
The structure of methylcholanthrene was established by the
synthesis of its degradation product, 5: 6-dimethyl- 1: 2-benzanthra-
quinone. Additional confirmation was afforded by the synthesis of
methylcholanthrene itself by Fieser and Seligman. This synthesis
consists in pyrolysis of the ketone arising from the interaction of
1-naphthylmagnesium bromide with 7-cyano-4-methylhydrindene,
and by this method it is possible to prepare considerable amounts of
methylcholanthrene. The parent hydrocarbon, cholanthrene, which
A co
CH3 6 CH3t 9CH
is likewise a potent carcinogenic compound, has been synthesised by
four different methods. One of these, due to Haslewood and
myself, takes advantage of the fact that ,3-alkyl-naphthalenes are
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brominated mainly in the contiguous a-position, and the final stages
are as follows:
Cholanthrene
Fieser and his colleagues have synthesised a series of compounds
designed to determine the structural features of the methylchol-
anthrene molecule which are necessary for carcinogenic activity.
This work has overlapped to some extent with investigations of
benzanthracene derivatives which have been in progress in my labor-
atory for several years, and we may at this stage discuss the relation-
ships between molecular structure and carcinogenic activity which
have been established among the benzanthracene derivatives.
We first became interested in benzanthracene derivatives in this
connection as aresult of the spectroscopic investigations of Mayneord
and Hieger, who found that the fluorescence spectrum of 1: 2-
benzanthracene bore considerable resemblance to that of carcinogenic
tars. As stated above, this latter spectrum was afterwards shown
to be due to 3: 4-benzpyrene. As the result of this resemblance
the synthesis of new benzanthracene deriva-
tives was initiated in our laboratory, in the
hope of procuring compounds which would
t 'T TI give a spectrum resembling even moreclosely
that of the cancer-producing tars. In the
meantime the finding of Kennaway that
1:2-Banzanthracene 1: 2: 5: 6-dibenzanthracene had cancer-pro-
ducing activity gave a very powerful stimulus
to these synthetic studies, and we now have a considerable range of
carcinogenic derivatives of 1: 2-benzanthracene, which include 3: 4-
benzpyrene and methylcholanthrene, both of which are seen to be
benzanthracene derivatives.
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It would be wearisome to attempt to catalogue the compounds
which have been prepared and tested in the course of this work,
but it is of interest to consider the relationships that have emerged
as the result of a study of one series of compounds, namely, the
methylbenzanthracenes. There are 12 possible positions of mono-
substitution in the unsymmetrical molecule of 1: 2-benzanthracene,
and the synthesis of the 12 monomethyl compounds, begun early
in 1930, has been completed within the last few months. The first
generalisation which emerged during the course of this work was
that substitution in certain positions could transform the biologically
inactive parent hydrocarbon into carcinogenic compounds, whereas
substitution in the other positions was without influence. At quite
an early stage it became evident that positions 5 and 6 were
favourable positions of substitution for the manifestation of car-
cinogenic activity. This has been confirmed by a study of com-
pounds with substituents other than methyl groups. It was found
further that substituents in both these positions produced greater
activity than a single substitution in either position. This is illus-
trated by the marked carcinogenic activity of 5: 6-dimethyl-1: 2-
benzanthracene, 5: 6-cyclopenteno-1: 2-benzanthracene, and 1: 2: 5:
6-dibenzanthracene.
An important development which occurred during the past year
was the recognition that the two meso positions 9 and 10 are also
favourable positions of substitution for the development of carcino-
genic properties. The meso methyl benzanthracenes necessary for
these studies were synthesised independently at almost the same
time at Harvard and in London, and from the results now available
the most potent of the monomethyl benzanthracenes is undoubtedly
the 10-compound, which gives sarcomas almost as rapidly as the
cholanthrene hydrocarbons when injected into mice, but is rather
less rapid than these compounds in the production of skin tumours.
Thus, of the twelve monomethyl benzanthracenes four (with sub-
stituents at positions 5, 6, 9, and 10) have pronounced carcnogenic
properties. Of the other eight, the 3-methyl compound gave no
skin tumours in mice, but has given subcutaneous tumours when
injected; the 8-methyl compound has been under test for such a
short time that no opinion can yet be expressed as to carcinogenic
activity; the remaining six compounds seem to be inactive.
The carcinogenic activity of the meso methyl benzanthracenes
provides at once a direct correlation between the potent carcinogenic
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compounds 3: 4-benzpyrene and methylcholanthrene, for the former
is a 9-substituted benzanthracene derivative, and the latter a 10-sub-
stituted derivative. Moreover, it has become increasingly apparent
that the presence ofsubstituents in more than one favourable position
tends to be an additive effect. Fieser has shown that 5: 10-
dimethyl-1: 2-benzanthracene is more potent than either the 5- or
10-monomethyl compounds, and Newman has found that a similar
consideration applies to 5: 9-dimethyl-1: 2-benzanthracene. In the
light of these facts it is not surprising that methylcholanthrene, with
simple substituents in no less than 3 favourable positions should be
such a potent cancer-producing compound. Also, it was clearly of
interest to examine 9: 10-dimethyl-1: 2-benzanthracene. We were
occupied with the synthesis of this compound when we learned from
Dr. Bachmann, of the University of Michigan, that he had prepared
it and we have carried out tests with a specimen synthesised by
him. The results have been little short of spectacular. In scarcely
more than 30 days tumours began to appear on the skin of the
mice to which this compound was applied. This is less than half the
time required for tumour formation with methylcholanthrene. The
mice used in this test were also characterised by the simultaneous
appearance of a number of warts on each animal, averaging about
4 per mouse. Subsequent histological examination showed that
these tumours were genuine epitheliomas, and from the standpoint
of rapidity of action this new hydrocarbon (9: 10-dimethyl-1: 2-
benzanthracene) is by far the most potent synthetic carcinogenic
compound yet obtained. It is clear from the results which have
been reviewed that carcinogenic activity among the benzanthracene
homologues is a property partly determined by, and dependent
upon, molecular structure.
Influence of Structural Modification on Carcinogenic Activ'ity
Numerous compounds related to the carcinogenic hydrocarbons
have now been tested for cancer-producing properties, and although
a number of interesting relationships have emerged it is difficult to
correlate the effects of structural alteration. On the one hand com-
paratively slight changes may have a profound influence on carcino-
genic activity, while on the other hand it has frequently been found
that activity is retained after quite gross alterations of structure.
In general, it appears that the activity is primarily determined by
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the superficial form of the molecule, but at the same time it is
obvious that details of structure may be very important.
Hydrogenation of the aromatic ring system contained in the
carcinogenic hydrocarbons is usually attended by complete loss of
activity, although it seems likely that slight activity is retained by
certain dihydro compounds which may, however, exert this activity
by virtue of their ready dehydrogenation to the aromatic structure.
Simple alkyl groups, which, as we have seen, may under favourable
conditions promote carcinogenic activity, will often have an adverse
effect on the activity of a potent compound. There are several
examples of derivatives of 1: 2: 5: 6-dibenzanthracene which sup-
port this thesis, and Winterstein has described an inactive methyl
3:4:5:6-dibenzacridine
1:2:5:6-dibenzfluorene 1:2:5:6-dibenz-
acridine"
3 :~~~~~~~~~1256-dibenz-
3:4:5:6-diben2carbazole carbazble
1:2: 7:8-dibenzcarbazole 1:2:5:6-dibenzphenazine
derivative of the highly active 3: 4-benzpyrene. The effect of
addition of another ring is usually to destroy activity (e.g.,
1: 2: 3: 4: 5: 6-tribenzanthracene and 2': 3'-naphtha-3: 4-pyrene are
both inert), but this is not invariably so. Both 1: 2: 3:4- and
3: 4: 8: 9-dibenzpyrene have pronounced carcinogenic activity.
The influence of introducing oxygen and nitrogen into the mole-
cule has been studied, although not very extensively so far. Here,
also, the all-important factor is probably the position of substitution.
Carcinogenic activity has been found in the meso amino and meso
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methoxy derivatives of 1: 2: 5: 6-dibenzanthracene, but complete
inactivity was shown by 3-hydroxymethylcholanthrene, 4'-hydroxy-
3: 4-benzpyrene, and their respective methyl ethers. On the other
hand, Fieser and his collaborators have reported the production of
tumours by 3-hydroxy-1: 2-benzanthracene; that is, by a hydroxy
derivative of a non-carcinogenic hydrocarbon.
An interesting series of compounds in which various modifica-
tions are made in the molecules of 1: 2: 5: 6-dibenzanthracene and
the very feebly carcinogenic 1: 2: 7: 8-dibenzanthracene is that
represented by the preceding formulae. The structural modifica-
tions involve the introduction of nitrogen into the middle ring of
the molecule, or contraction of this ring to a five-membered ring,
or both of these changes. The first five of these compounds have
all given tumours, although the latent period is very prolonged
(about 300 days). The dibenzphenazine proved inactive, and
Boyland and Brues, who tested the carbazole derivatives, found
very slight activity in the 1: 2: 7: 8-dibenzcarbazole.
Carcinogenic Hydrocarbons not related to 1: 2-benzanthracene
This brief survey may be conduded with a reference to recent
experiments which show that the 1: 2-benzanthracene type of struc-
ture is not essential for carcinogenic activity among the polycyclic
hydrocarbons. Fieser has, in the course of his experiments on the
simplification of the methylcholanthrene molecule, prepared an
analogue of cholanthrene, 5: 10-dimethylene-1: 2-cyclopentenoan-
thracene, in which the 1: 2-benz ring of cholanthrene is replaced by
a five-membered carbon ring. This compound gave tumours in 3
out of 20 mice within 10 months of the commencement of injections
of a solution in lard.
There are, moreover, indications that considerable carcinogenic
potency may be shown by polycydic hydrocarbons unrelated to
anthracene. Several years ago I synthesised 3: 4-benzphenanthrene
and this compound gave tumours of the skin in a large proportion
of the mice treated, but the latent period was as long as 15 months
or so. This line of work is now being actively extended by my
colleague, C. L. Hewett, who has found in 2-methyl-3:4-benz-
phenanthrene a carcinogenic compound which is almost as potent
as cholanthrene, and he has also prepared 1: 2: 3: 4-dibenzphenan-
threne which has begun to yield epithelial tumours after 4 months.
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By condensing 1-bromo-2-naphthylacetic acid with aromatic alde-
hydes and thenbringing about cyclisation by elimination of hydrogen
bromide with fused potash, Hewett has developed a method which
is provingveryuseful
in the synthesis of
these hitherto rela- rH
tively inaccessible 3: Br is
4-benzphenanthrene Cfk2T 2
C02
derivatives, e.g.,
It is evident that the capacity to induce malignant tumours is a
propertywhich is shared by many different compounds. It is impos-
sible at the present stage to explain this property, and it seems
useless to attempt to define any common feature of molecular struc-
ture. Nevertheless, the availability of a wide range of carcinogenic
compounds and doselyrelated inactive substances has provided much
material for the investigation of the mode of their biological action.
Already there are several observations which may prove to be of
considerable significance, and it seems justifiable to express the belief
that the mechanism of carcinogenesis by these chemical substances
will in due time be laid bare by further experimental work.
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